CapWealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8M Buy
10,188
+962
+10% +$1.14M 0.89% 45
2026
Q2
$11.1M Buy
9,226
+311
+3% +$318K 0.76% 47
2026
Q1
$8.2M Buy
8,915
+8,534
+2,240% +$8.65M 0.61% 51
2025
Q4
$409K Buy
381
+3
+0.8% +$2.87K 0.03% 99
2025
Q3
$288K Sell
378
-15
-4% -$11.2K 0.02% 103
2025
Q2
$306K Sell
393
-69
-15% -$53.6K 0.03% 88
2025
Q1
$382K Buy
462
+19
+4% +$15.8K 0.04% 79
2024
Q4
$342K Hold
443
– – 0.04% 82
2024
Q3
$392K Buy
443
+5
+1% +$4.5K 0.04% 80
2024
Q2
$397K Buy
438
+15
+4% +$12K 0.05% 71
2024
Q1
$329K Hold
423
– – 0.04% 77
2023
Q4
$247K Hold
423
– – 0.03% 90
2023
Q3
$227K Buy
+423
New +$218K 0.03% 98
2014
Q3
– Sell
-300
Closed -$19K – 377
2014
Q2
$19K Sell
300
-125
-29% -$7.46K ﹤0.01% 193
2014
Q1
$25K Hold
425
– – 0.01% 179
2013
Q4
$22K Hold
425
– – 0.01% 201
2013
Q3
$21K Hold
425
– – 0.01% 235
2013
Q2
$21K Buy
+425
New +$23.1K 0.01% 221

Other funds holding LLY

CapWealth Advisors's LLY Position: Q3 2026 in Review

CapWealth Advisors increased its Eli Lilly (LLY) stake by 10% in Q3 2026, buying an estimated $1.14M and bringing the position to 10,188 shares worth $11.8M. The position accounts for 0.89% of the portfolio, ranked #45.

CapWealth Advisors first reported a position in LLY in Q2 2013 and has held it in 18 quarters since. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • CapWealth Advisors held 10,188 shares of Eli Lilly worth $11.8M as of Q3 2026.
  • CapWealth Advisors bought 962 Eli Lilly shares in Q3 2026, an estimated $1.14M.
  • Eli Lilly made up 0.89% of CapWealth Advisors's portfolio in Q3 2026, its #45 holding.
  • CapWealth Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 18 quarters since.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on CapWealth Advisors's 13F filing for Q3 2026, filed 5 Oct 2026.